|
" Retaining or Retrieving Older and Trying to Identify Novel Rodenticides "
Eason, Charles; Murphy, Elaine; Sam, Shona; Ross, James; Blackie, Helen; Henderson, Ray; Shapiro, Lee; MacMorran, Duncan; Gibson, Troy; Gregory, Neville; Conole, Daniel; Rennison, David; Brimble, Margaret
| Document Type
|
:
|
AL
|
| Record Number
|
:
|
943728
|
| Doc. No
|
:
|
LA15s2f0w9
|
| Language of Document
|
:
|
English
|
| Main Entry
|
:
|
Eason, Charles; Murphy, Elaine; Sam, Shona; Ross, James; Blackie, Helen; Henderson, Ray; Shapiro, Lee; MacMorran, Duncan; Gibson, Troy; Gregory, Neville; Conole, Daniel; Rennison, David; Brimble, Margaret
|
| Title & Author
|
:
|
Retaining or Retrieving Older and Trying to Identify Novel Rodenticides [Article]\ Eason, Charles; Murphy, Elaine; Sam, Shona; Ross, James; Blackie, Helen; Henderson, Ray; Shapiro, Lee; MacMorran, Duncan; Gibson, Troy; Gregory, Neville; Conole, Daniel; Rennison, David; Brimble, Margaret
|
| Title of Periodical
|
:
|
Proceedings of the Vertebrate Pest Conference
|
| Volume/ Issue Number
|
:
|
25
|
| Date
|
:
|
2012
|
| Abstract
|
:
|
Anticoagulant compounds are likely to play an important role in the control of commensal rodents for crop protection and conservation for the foreseeable future. However, there are concerns regarding their persistence and the development of more widespread resistance. We are seeking to retrieve and retain older alternatives as well as developing novel rodenticides. Our three-pronged approach is, firstly, to improve the performance of older non-anticoagulant rodenticides, such as sodium fluoroacetate (1080) and zinc phosphide; secondly to optimise the performance of 1st-generation anticoagulants; and thirdly, to identify alternatives to anticoagulant rodenticides with the same mode of action as para-aminopropiophenone (PAPP), which was registered in New Zealand as a predacide in April 2011. Zinc phosphide was also registered in New Zealand for the first time in 2011, and combinations of ultra-low-dose cholecalciferol with first generation anticoagulants are being advanced to provide the performance characteristics of a 2nd-generation anticoagulant with a lower risk of bioaccumulation and secondary poisoning.
|
| |